Public Service Enterprise Group Incorporated (PEG)

Regulus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	11,134	10,290	11,237	9,800	9,722	9,603
Revenue Growth (YoY)	8.69%	-8.43%	14.66%	0.80%	1.24%	-4.69%
Fuel & Purchased Power	3,676	3,393	3,260	4,018	3,499	3,056
Operations & Maintenance	3,482	3,316	3,132	3,149	3,185	3,080
Depreciation & Amortization	1,230	1,182	1,135	1,100	1,216	1,285
Other Operating Expenses	-28	-33	236	-347	-300	-214
Total Operating Expenses	8,360	7,858	7,763	7,920	7,600	7,207
Operating Income	2,774	2,432	3,474	1,880	2,122	2,396
Interest Expense	-948	-882	-748	-628	-571	-600
Interest Income	117	113	121	93	79	74
Net Interest Expense	-831	-769	-627	-535	-492	-526
Income (Loss) on Equity Investments	-	1	1	14	16	14
Allowance for Borrowed Funds for Construction	42	41	60	65	71	-
Other Non-Operating Income (Expenses)	-5	-1	-9	-34	-52	41
EBT Excluding Unusual Items	1,980	1,704	2,899	1,390	1,665	1,925
Gain (Loss) on Sale of Investments	128	127	189	-265	194	253
Gain (Loss) on Sale of Assets	-6	-6	-7	-123	-2,637	123
Other Unusual Items	-	-	-	-	-311	-
Pretax Income	2,102	1,825	3,081	1,002	-1,089	2,301
Income Tax Expense	122	53	518	-29	-441	396
Net Income	1,980	1,772	2,563	1,031	-648	1,905
Net Income to Common	1,980	1,772	2,563	1,031	-648	1,905
Net Income Growth	19.93%	-30.86%	148.59%	-	-	12.52%
Shares Outstanding (Basic)	499	498	498	498	504	504
Shares Outstanding (Diluted)	500	500	500	501	504	507
Shares Change (YoY)	-	-	-0.20%	-0.60%	-0.59%	-
EPS (Basic)	3.97	3.56	5.15	2.07	-1.29	3.78
EPS (Diluted)	3.96	3.54	5.13	2.06	-1.29	3.76
EPS Growth	20.00%	-30.99%	149.03%	-	-	12.91%
Free Cash Flow	-644	-1,247	481	-1,385	-983	179
Free Cash Flow Per Share	-1.29	-2.49	0.96	-2.76	-1.95	0.35
Dividend Per Share	2.460	2.400	2.280	2.160	2.040	1.960
Dividend Growth	5.13%	5.26%	5.56%	5.88%	4.08%	4.25%
Profit Margin	17.78%	17.22%	22.81%	10.52%	-6.67%	19.84%
Free Cash Flow Margin	-5.78%	-12.12%	4.28%	-14.13%	-10.11%	1.86%
EBITDA	4,203	3,805	4,798	3,163	3,525	3,865
EBITDA Margin	37.75%	36.98%	42.70%	32.28%	36.26%	40.25%
D&A For EBITDA	1,429	1,373	1,324	1,283	1,403	1,469
EBIT	2,774	2,432	3,474	1,880	2,122	2,396
EBIT Margin	24.92%	23.64%	30.92%	19.18%	21.83%	24.95%
Effective Tax Rate	5.80%	2.90%	16.81%	-	-	17.21%

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.

SEC Filings: 10-K · 10-Q